Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 288 entries
View as:

The Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT01743287 Org: User:
Start: 12/31/12 End: 04/30/15 Due: 04/30/16

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04906785 Org: User:
Start: 06/04/21 End: 08/06/21 Due: 08/06/22

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150

Phase: N/A Priority: Normal
NCT ID: NCT04334213 Org: User:
Start: 05/07/20 End: 08/05/20 Due: 08/05/21

A Clinical Study to Evaluate the Efficacy and Safety of CKD-351

Phase: N/A Priority: Normal
NCT ID: NCT03762369 Org: User:
Start: 12/07/18 End: 05/30/22 Due: 05/30/23

Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet

Phase: N/A Priority: Normal
NCT ID: NCT02589457 Org: User:
Start: 10/31/15 End: 12/31/15 Due: 12/31/16

To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01682564 Org: User:
Start: 01/31/12 End: 10/31/14 Due: 10/31/15

CKD-828 Drug Interaction Study (Telmisartan)

Phase: N/A Priority: Normal
NCT ID: NCT01356017 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05540912 Org: User:
Start: 09/15/22 End: 12/05/22 Due: 12/05/23

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)

Phase: N/A Priority: Normal
NCT ID: NCT04694989 Org: User:
Start: 02/20/21 End: 05/04/21 Due: 05/04/22

Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet

Phase: N/A Priority: Normal
NCT ID: NCT03437785 Org: User:
Start: 01/16/18 End: 10/12/18 Due: 10/12/19

Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03627182 Org: User:
Start: 04/26/18 End: 02/10/23 Due: 02/10/24

Efficacy and Safety of EsoDuo®

Phase: N/A Priority: Normal
NCT ID: NCT06430047 Org: User:
Start: 11/25/22 End: 05/31/25 Due: 05/31/26

Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

Phase: N/A Priority: Normal
NCT ID: NCT05549401 Org: User:
Start: 09/29/22 End: 12/09/22 Due: 12/09/23

Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337

Phase: N/A Priority: Normal
NCT ID: NCT03793985 Org: User:
Start: 09/05/18 End: 11/13/18 Due: 11/13/19

CKD-397 Drug-drug Interaction Study (B)

Phase: N/A Priority: Normal
NCT ID: NCT02247505 Org: User:
Start: 09/30/14 End: 12/31/14 Due: 12/31/15

A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT02005744 Org: User:
Start: 03/31/14 End: 02/29/16 Due: 02/28/17

A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05041790 Org: User:
Start: 09/30/21 End: 11/30/24 Due: 11/30/25

Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02356679 Org: User:
Start: 08/31/14 End: 06/30/15 Due: 06/30/16

Study to Evaluate the Safety and Pharmacokinetics of CKD-331

Phase: N/A Priority: Normal
NCT ID: NCT05335044 Org: User:
Start: 05/31/22 End: 07/12/22 Due: 07/12/23

CKD-391 Pharmacokinetic Study Phase I

Phase: N/A Priority: Normal
NCT ID: NCT02501200 Org: User:
Start: 08/31/15 End: 12/31/15 Due: 12/31/16

Efficacy and Safety of CKD-828 to Stage 2 Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01634295 Org: User:
Start: 07/31/12 End: 05/31/13 Due: 05/31/14

A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06727396 Org: User:
Start: 11/14/24 End: 05/31/25 Due: 05/31/26

A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01497873 Org: User:
Start: 09/30/10 End: 03/31/18 Due: 03/31/19

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

Phase: N/A Priority: Normal
NCT ID: NCT06110923 Org: User:
Start: 10/24/23 End: 12/31/24 Due: 12/31/25

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03646799 Org: User:
Start: 08/30/18 End: 09/14/18 Due: 09/14/19